prestige bio pbp1510 cancer
Scope
Date
~
-
Bio & Pharma
Korean biotech L&C Bio issues convertible bonds worth $46 mn
South Korean biotech company L&C Bio, which specializes in tissue regeneration treatment, is poised to ramp up its expansion into the Chinese ma...
Jun 30, 2022 (Gmt+09:00)
language -
Bio & Pharma
Lotte plans to expand bio capacity in Korea and US
Lotte Group is preparing to kickstart its biopharmaceutical business as a contract development and manufacturing company (CDMO) by building a new pl...
Jun 16, 2022 (Gmt+09:00)
language -
Bio & Pharma
Korean bio firms flock to US as SV Invest eyes $100 million bio fund
SV Investment, a South Korean venture capital and private equity firm, is looking to launch a $100 million bio fund in the US as a growing number of...
Jun 13, 2022 (Gmt+09:00)
language -
Behind the Scenes
Samsung in do-or-die race with $355 bn spending plan
"It's not a matter of numbers, but a matter of do or die for us."This is the first public remark from Samsung Electronics Co. Vice Chairman and de f...
May 26, 2022 (Gmt+09:00)
language -
Corporate investment
SK takes aim at chips, batteries, bio with $195 billion investment
SK Group, South Korea’s second-largest conglomerate after Samsung, on Thursday announced a plan to invest 247 trillion won ($195 billion) in k...
May 26, 2022 (Gmt+09:00)
language -
Corporate investment
Bio, mobility to top Lotte's $30 bn spending list by 2026
South Korea’s Lotte Group will spend a total of 37 trillion won ($29 billion) on its businesses over the next five years, a chunk of which wil...
May 25, 2022 (Gmt+09:00)
language -
Corporate investment
Samsung to invest $355 billion in chip, biotech, 6G over five years
South Korea’s top conglomerate Samsung has unveiled a plan to invest 450 trillion won ($355 billion) over the next five years in strategic sec...
May 24, 2022 (Gmt+09:00)
language -
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Carbon neutrality
Hyundai Oilbank steps up eco-friendly white bio business
Hyundai Oilbank Co., a South Korean petroleum and refinery company, is slated to tap into the white biotechnology market. The company has selected w...
May 11, 2022 (Gmt+09:00)
-
Pension funds
POBA targets PE in tech, bio, healthcare in long term, CIO says
Public Officials Benefit Association (POBA) of South Korea will keep its focus on steady cash flow while strengthening profitability, its Chief Inve...
May 09, 2022 (Gmt+09:00)
-
IPOs
Korea’s tough IPO review drives bio startup to Nasdaq
A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...
Apr 22, 2022 (Gmt+09:00)
-
Bio & Pharma
FutureChem seeks FDA nod for prostate cancer radiopharma trials
FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...
Apr 20, 2022 (Gmt+09:00)
-
IPOs
Korean IPOs delayed after bourse's sweeping reshuffle
Scores of South Korean initial public offerings slated for the first half of this year have been delayed after the bourse operator carried out a lar...
Mar 17, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Private equity
Korean SPAC Valuence Merger debuts on Nasdaq, targets bio M&As
Valuence Merger Corp. 1, a special purpose acquisition company (SPAC), led by South Korean fund managers, has debuted on the Nasdaq, targeting Asian...
Mar 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio ventures struggle with fundraising
Biopharmaceutical companies of South Korea are having a tough time fundraising of late. Bio ventures without specific public offering plans are pa...
Mar 01, 2022 (Gmt+09:00)
-
Corporate restructuring
SK's 5-year journey toward batteries, bio and chips
Back in January 2017, SK Group Chairman Chey Tae-won emphasized the need for “deep change," in his New Year message and presented the phrase a...
Jan 23, 2022 (Gmt+09:00)
-
Pharmaceuticals
ABL Bio in $1.06 bn deal with Sanofi for Parkinson's disease treatment
South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...
Jan 12, 2022 (Gmt+09:00)
-
Private equity
CICC to form up to $3.3 bn funds for bio, chips in Korea and others
CICC Capital, a private equity firm of China's largest investment bank China International Capital Corporation (CICC), will create funds with a comb...
Jan 10, 2022 (Gmt+09:00)
language -
COVID-19
SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...
Dec 24, 2021 (Gmt+09:00)
language -
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Economy
Korea exports hit record to top $640 bn in 2021
South Korea’s exports have reached an all-time high thanks to strong overseas demand for key products such as semiconductors amid the global e...
Dec 14, 2021 (Gmt+09:00)
language -
Bio
K-bio's out-licensing this year reaches $9.3 bn
Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...
Nov 18, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
CJ Cheiljedang to acquire Dutch bio firm Batavia for 195 million euros
CJ Cheiljedang Corp., a key subsidiary of South Korea’s food and entertainment conglomerate CJ Group, said on Monday it is acquiring Batavia B...
Nov 08, 2021 (Gmt+09:00)
-
Bio
Sartorius to invest $300 mn in bio material, equipment plant in Korea
Sartorius AG, German laboratory equipment and raw material maker, is slated to invest $300 million in the next three years to build a plant in South...
Nov 03, 2021 (Gmt+09:00)
language -
Shareholder activism
SK Chem says no immediate plan to sell SK Bioscience stake
SK Chemicals Co., the top shareholder of South Korea's SK Bioscience Co., is not considering reducing its stake in the vaccine maker in the immediat...
Nov 02, 2021 (Gmt+09:00)
-
Korean startups
Portrai to revolutionize biopsy quality through AI technology
Biopsy is one of the most used methods to examine a person’s illness, taking a tissue sample of a patient for analysis. Usually, the samples a...
Oct 06, 2021 (Gmt+09:00)
-
Biotech
JW Bioscience in pancreatic cancer biomarker deal with Immunovia
JW Bioscience Co., a subsidiary of South Korea’s JW Life Science Co., has signed a non-exclusive agreement to transfer its patented technology...
Sep 15, 2021 (Gmt+09:00)
language -
Chemical Industry
LG Chem, ADM to build JV in US to produce bioplastics made from corn
South Korea’s LG Chem Ltd. said on Tuesday it is jointly building a corn-based bioplastic plant in the US with Archer Daniels Midland Co., a g...
Sep 14, 2021 (Gmt+09:00)
language -
Batteries
POSCO, GS join hands to expand battery, hydrogen business
POSCO and GS Group have teamed up to expand their battery recycling and hydrogen businesses. The move came as South Korea’s top steelmaker POS...
Sep 07, 2021 (Gmt+09:00)
language
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand